List of Tables
Table 1. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Proton pump inhibitors
Table 3. Key Players of H2 Receptor Antagonists
Table 4. Key Players of Antacids
Table 5. Key Players of Others
Table 6. Global Nonerosive Reflux Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nonerosive Reflux Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nonerosive Reflux Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nonerosive Reflux Disease Treatment Market Share by Region (2020-2025)
Table 10. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nonerosive Reflux Disease Treatment Market Share by Region (2026-2031)
Table 12. Nonerosive Reflux Disease Treatment Market Trends
Table 13. Nonerosive Reflux Disease Treatment Market Drivers
Table 14. Nonerosive Reflux Disease Treatment Market Challenges
Table 15. Nonerosive Reflux Disease Treatment Market Restraints
Table 16. Global Nonerosive Reflux Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nonerosive Reflux Disease Treatment Market Share by Players (2020-2025)
Table 18. Global Top Nonerosive Reflux Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonerosive Reflux Disease Treatment as of 2024)
Table 19. Ranking of Global Top Nonerosive Reflux Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nonerosive Reflux Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nonerosive Reflux Disease Treatment, Headquarters and Area Served
Table 22. Global Key Players of Nonerosive Reflux Disease Treatment, Product and Application
Table 23. Global Key Players of Nonerosive Reflux Disease Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nonerosive Reflux Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Nonerosive Reflux Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Nonerosive Reflux Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nonerosive Reflux Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nonerosive Reflux Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nonerosive Reflux Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. AstraZeneca Company Details
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Nonerosive Reflux Disease Treatment Product
Table 51. AstraZeneca Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. Eisai Company Details
Table 54. Eisai Business Overview
Table 55. Eisai Nonerosive Reflux Disease Treatment Product
Table 56. Eisai Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 57. Eisai Recent Development
Table 58. GlaxoSmithKline Company Details
Table 59. GlaxoSmithKline Business Overview
Table 60. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product
Table 61. GlaxoSmithKline Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 62. GlaxoSmithKline Recent Development
Table 63. Takeda Pharmaceutical Company Details
Table 64. Takeda Pharmaceutical Business Overview
Table 65. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product
Table 66. Takeda Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 67. Takeda Pharmaceutical Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Nonerosive Reflux Disease Treatment Product
Table 71. Johnson & Johnson Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Daewoong Pharmaceutical Company Details
Table 74. Daewoong Pharmaceutical Business Overview
Table 75. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product
Table 76. Daewoong Pharmaceutical Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 77. Daewoong Pharmaceutical Recent Development
Table 78. Ironwood Pharmaceuticals Company Details
Table 79. Ironwood Pharmaceuticals Business Overview
Table 80. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product
Table 81. Ironwood Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 82. Ironwood Pharmaceuticals Recent Development
Table 83. SRS Pharmaceuticals Company Details
Table 84. SRS Pharmaceuticals Business Overview
Table 85. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product
Table 86. SRS Pharmaceuticals Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 87. SRS Pharmaceuticals Recent Development
Table 88. SFJ Pharmaceuticals Group Company Details
Table 89. SFJ Pharmaceuticals Group Business Overview
Table 90. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product
Table 91. SFJ Pharmaceuticals Group Revenue in Nonerosive Reflux Disease Treatment Business (2020-2025) & (US$ Million)
Table 92. SFJ Pharmaceuticals Group Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Nonerosive Reflux Disease Treatment Picture
Figure 2. Global Nonerosive Reflux Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nonerosive Reflux Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Proton pump inhibitors Features
Figure 5. H2 Receptor Antagonists Features
Figure 6. Antacids Features
Figure 7. Others Features
Figure 8. Global Nonerosive Reflux Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nonerosive Reflux Disease Treatment Market Share by Application: 2024 VS 2031
Figure 10. Retail Pharmacies Case Studies
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Nonerosive Reflux Disease Treatment Report Years Considered
Figure 14. Global Nonerosive Reflux Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Nonerosive Reflux Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Nonerosive Reflux Disease Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Nonerosive Reflux Disease Treatment Market Share by Players in 2024
Figure 18. Global Top Nonerosive Reflux Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonerosive Reflux Disease Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Nonerosive Reflux Disease Treatment Revenue in 2024
Figure 20. North America Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Nonerosive Reflux Disease Treatment Market Share by Country (2020-2031)
Figure 22. United States Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nonerosive Reflux Disease Treatment Market Share by Country (2020-2031)
Figure 26. Germany Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nonerosive Reflux Disease Treatment Market Share by Region (2020-2031)
Figure 34. China Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nonerosive Reflux Disease Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nonerosive Reflux Disease Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Nonerosive Reflux Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 50. Eisai Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 54. Daewoong Pharmaceutical Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 55. Ironwood Pharmaceuticals Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 56. SRS Pharmaceuticals Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 57. SFJ Pharmaceuticals Group Revenue Growth Rate in Nonerosive Reflux Disease Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
